Scipher Medicine Corp
Formerly DZZOM Delaware Corp.
Funding rounds
4 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| May 2024 | $6 M | No. 4 | $2 to $10 million | equity, options | SEC | |
| Mar 2021 | $82 M | No. 3 | $50 to $250 million | equity | SEC | |
| May 2019 | $25 M | No. 2 | $10 to $50 million | equity | SEC | |
| Aug 2018 | $9 M | No. 1 | $2 to $10 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Scipher Medicine Corp chose not to state its revenue in its newest notice of a funding round (Jul 2024).
SEC Form D · Jul 2024
The industry group it chose in its notices: Biotechnology.
SEC Form D · Jul 2024
That is all the official record says: Scipher Medicine Corp has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Scipher Medicine Corp is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 15 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Reginald Seeto | Executive officer | Jul 2024 |
| Alif Saleh | Executive officer | Mar 2021 |
| Jeffrey Sachs | Executive officer | Mar 2021 |
| Byron Kalogerou | Executive officer | Oct 2019 |
| Albert-Laszlo Barabasi | Director | Jul 2024 |
| Glenn Muir | Director | Jul 2024 |
| Ingo Chakravarty | Director | Jul 2024 |
| Joseph Loscalzo | Director | Jul 2024 |
| Miklos Kobor | Director | Jul 2024 |
| Reginald Seeto | Director | Jul 2024 |
| Samir Kaul | Director | Jul 2024 |
| Tim Anderson | Director | Jul 2024 |
| Todd Sone | Director | Jul 2024 |
| Albert Laszlo Barabasi | Director | Mar 2021 |
| Alif Saleh | Director | Mar 2021 |
| Michael Rubin | Director | Mar 2021 |